Dr Oliver Klein is a medical oncologist and a clinical scientist at the Olivia Newton John Cancer Centre. He has undertaken his training in Medical Oncology and Clinical Haematology in Germany before coming to Australia in 2005 to join the Ludwig Institute for Cancer Research at the Austin Hospital. He has worked for several years as a postdoctoral and clinical research fellow being actively involved in melanoma and cancer immunotherapy research. 

Dr Klein has extensive experience in the management of patients with melanoma and a particular interest in immuno-oncology. He has lead an investigator-initiated clinical trial that demonstrated unprecedented clinical efficacy of immunotherapy using checkpoint inhibitors in patients with advanced rare cancers. He holds public hospital appointments with the Austin Hospital and the Olivia Newton John Cancer Centre where he heads up an immuno-oncology clinic. 

Dr Klein’s research is focused on exploring the most up to date and novel way to treat cancer by harnessing the body’s immune system’s ability to fight cancer. He currently is involved in numerous clinical trials and continues to publish in scientific journals and present at national and international conferences. 

Dr Klein is committed to providing the latest and most advanced care available to treat cancer. He believes that a strong connection between the patient and the treating oncologist is important in getting the best outcomes for patients with cancer.